By Matthew Keck —
The University of Louisville’s Division of Infectious Diseases and Pfizer Inc. announced they are collaborating on epidemiological research Jan. 23. The research will be related to vaccine-preventable diseases affecting adults, including the elderly.
“U of L’s Division of Infectious Diseases has a rich history of collaboration with Pfizer through the successful implementation of numerous clinical epidemiological research studies,” said Julio Ramirez, chief of the Division of Infectious Diseases at U of L. “We are excited to formalize a long-term collaboration that builds on these past successes.”
U of L is the first Center of Excellence designated by Pfizer Vaccines for this type of research.